2192.HK HKSE
Medlive Technology Co., Ltd.
1W: -6.7%
1M: -11.2%
3M: -14.0%
YTD: -36.0%
1Y: -56.9%
3Y: +4.5%
HK$6.43 ($0.82)
-0.31 (-4.60%)
Weekly Expected Move ±4.3%
HK$6
HK$6
HK$6
HK$7
HK$7
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$108M
+6.3% ▲
5Y CAGR: +30.9%
Capital Expenditures
$21M
+35.8% ▲
5Y CAGR: +53.8%
Free Cash Flow
$87M
+26.1% ▲
5Y CAGR: +27.7%
Dividends Paid
$179M
-43.6% ▼
Buybacks
$0
+100.0% ▲
Net Change in Cash
$79M
+113.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $105M | $70M | $135M | $253M | $340M |
| Depreciation & Amort. | $5M | $6M | $9M | $9M | $16M |
| Stock-Based Comp. | $0 | $14M | $17M | $10M | $6M |
| Change in Working Capital | $18M | -$28M | -$10M | $22M | -$28M |
| Other Non-Cash Items | -$17M | -$4M | -$75M | -$193M | -$226M |
| Operating Cash Flow | $111M | $44M | $77M | $102M | $108M |
| — Investing Activities — | |||||
| Capital Expenditures | -$626K | -$2M | -$7M | -$750K | $0 |
| Acquisitions (Net) | -$639K | -$53M | -$43M | -$56M | $0 |
| Investment Purchases | -$132M | -$5M | -$3.6B | -$702M | $0 |
| Investment Sales | $133M | $5M | $720K | $3M | $0 |
| Other Investing | $639K | $4M | $44M | $121M | $111M |
| Investing Cash Flow | $13K | -$51M | -$3.6B | -$635M | $111M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | -$4M | -$5M | -$6M | -$13M |
| Stock Repurchased | $0 | $0 | $0 | -$683K | $0 |
| Dividends Paid | $0 | -$92M | -$12M | -$125M | -$179M |
| Other Financing | -$209K | -$145M | -$5M | -$2M | -$8M |
| Financing Cash Flow | -$3M | $3.8B | -$22M | -$133M | -$198M |
| Net Change in Cash | $108M | $3.7B | -$3.2B | -$603M | $79M |
| Cash End of Period | $147M | $3.9B | $678M | $75M | $154M |
| Free Cash Flow | $110M | $42M | $70M | $69M | $87M |